CN1200724C - Pill for activating collateral flow and removing spur - Google Patents

Pill for activating collateral flow and removing spur Download PDF

Info

Publication number
CN1200724C
CN1200724C CN 03100007 CN03100007A CN1200724C CN 1200724 C CN1200724 C CN 1200724C CN 03100007 CN03100007 CN 03100007 CN 03100007 A CN03100007 A CN 03100007A CN 1200724 C CN1200724 C CN 1200724C
Authority
CN
China
Prior art keywords
radix
gram
pill
examples
collateral flow
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN 03100007
Other languages
Chinese (zh)
Other versions
CN1425446A (en
Inventor
黄远清
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN 03100007 priority Critical patent/CN1200724C/en
Publication of CN1425446A publication Critical patent/CN1425446A/en
Application granted granted Critical
Publication of CN1200724C publication Critical patent/CN1200724C/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Abstract

The present invention relates to a pill for activating blood circulation and eliminating spurs, which selects 5 to 15g of lanceleaf anisetree root, 5 to 15g of hemlock parsley, 36 to 46g of stir-baked radix paeoniae alba with vino, 11 to 21g of ningpo yam rhizome, 11 to 21g of common floweringquince fruit, 11 to 21g of clematis root, 11 to 21g of angelica, 11 to 21g of kudzuvine root, 11 to 21g of radix dipsaci from sichuan of china, 11 to 21g of medicinal cyathula root, 11 to 21g of Chinese starjasmine stem, 11 to 21g of mulberry twig, 11 to 21g of peach seed, 26 to 36g of suberect spatholobus stem, 26 to 36g of bryozoatum, 6 to 16g of safflower, 6 to 16g of licorice and 16 to 20g of yam. All the raw materials are ground into powder and prepared into pills. The pill for activating blood circulation and eliminating spurs is used for treating arthralgia caused by rheumatism, hyperostosis, limb numbness, injuries from falls, sprain and sciatica, and has the advantages of higher efficiency than conventional medicines or conventional treatment methods, simple manufacture technology, small side effect, convenient taking and convenient carrying.

Description

Pill for activating collateral flow and removing spur
Technical field:
The present invention relates to a kind of Chinese medicine preparation, be meant a kind of Pill for activating collateral flow and removing spur especially.
Background technology:
Rheumatism, rheumatoid, sciatica, theory of Chinese medical science are thought and are belonged to the arthromyodynia scope, are mostly that QI and blood is not smooth because wind-cold damp pathogen goes into to cause blockage of main and collateral channels outward.Hyperosteogeny is a rheumatism involving the bone scope in the arthromyodynia, and the traditional Chinese medical science is thought, the kidney governing bones marrow, since kidney qi degradation after people in middle age, the undesired generation hypertrophy of its bone development of leading, and the compressing blood vessels influence QI-blood circulation.
Radix Illicii Lanceolati, Rhizoma Chuanxiong, Radix Paeoniae Alba, Rhizoma Dioscoreae Nipponicae, Fructus Chaenomelis, CHENGLINGXIAN, Radix Cyathulae, Caulis Trachelospermi and Caulis Spatholobi energy expelling wind and removing dampness, active blood stasis dispelling; Flos Carthami, Semen Persicae and the Radix Angelicae Sinensis diffusing expectorant of can invigorating blood circulation; Rhizoma Dioscoreae, Radix Dipsaci have bone and muscle strengthening, the effect of suppressing the hyperactive liver the kidney invigorating; The Pumex hard lump resolving and spur eliminating; The Radix Puerariae priming is up; Ramulus Mori priming extremity; The Radix Glycyrrhizae coordinating the actions of various ingredients in a prescription and the anti-property of medicine are partially.
Summary of the invention:
The objective of the invention is according to above-mentioned tcm theory, propose the Pill for activating collateral flow and removing spur of a kind of new treatment rheumatic arthralgia, hyperosteogeny, numb limbs and tense tendons, osteopatia sprain, sciatica.
Described purpose of the present invention can be achieved through the following technical solutions.
Pill for activating collateral flow and removing spur provided by the present invention is mixed by weight by following raw materials according:
Radix Illicii Lanceolati, each 5-15 gram of Rhizoma Chuanxiong, Radix Paeoniae Alba 36-46 gram, Rhizoma Dioscoreae Nipponicae, Fructus Chaenomelis, Radix Clematidis, Radix Angelicae Sinensis, Radix Puerariae, Radix Dipsaci, Radix Cyathulae, Caulis Trachelospermi, Ramulus Mori, each 11-21 gram of Semen Persicae, Caulis Spatholobi, each 26-36 gram of Pumex, Flos Carthami, each 6-16 gram of Radix Glycyrrhizae, Rhizoma Dioscoreae 16-20 gram.
The preparation method of described Pill for activating collateral flow and removing spur is through following steps:
Select proportion raw material as indicated above for use, all raw materials are ground into the end altogether, make general ball.
Pill for activating collateral flow and removing spur provided by the present invention can be used for treating rheumatic arthralgia, hyperosteogeny, numb limbs and tense tendons, osteopatia sprain, sciatica.
The instructions of taking of Pill for activating collateral flow and removing spur provided by the invention is, every day three times, and each 10 grams, eliminating cold for resuscitation water is for oral administration, and one month is a course of treatment.Contraindication in pregnancy, the careful usefulness of aged debility person.
In the clinical trial:
The clinical data of I, rheumatic arthritis is:
18 examples are organized in treatment, matched group 16 examples.Symptom characteristic: morning deadlock, the joint is pain, limitation of activity, symmetry enlargement for a long time, the rheumatoid factor latex agglutination test positive.
Treatment is organized in 18 examples, male's 6 examples, women's 12 examples, age 16-69 year.
5 examples have the swelling of limbs joint cold type of pain, local fear of cold, color of the leather not hot, pain increase in intensity under coldness, pain alleviated while getting warmth, arthralgia not red, that touch acute, are diagnosed as cold dampness accumulation pattern.Through taking Pill for activating collateral flow and removing spur provided by the invention after three courses of treatment, 1 routine clinical symptom disappearance, 4 examples take a turn for the better.
5 examples have muscle, arthralgia violent, are mostly sensation of pricking, and the position is fixing not to be moved, local swelling has scleroma or ecchymosis, scaly dry skin tarnish, xerostomia not to drink, be diagnosed as congestion resistance network type, through taking Pill for activating collateral flow and removing spur provided by the invention after five courses of treatment, clinical symptom disappearance.
6 routine arthroncuss, stupid numb pain, visible sucutaneous nodule scleroma, dizzy margins of eyelids, chest distress, desire evil, poor appetite, abundant expectoration glue in vain general, be diagnosed as phlegm-damp resistance network type, through taking Pill for activating collateral flow and removing spur provided by the invention after three courses of treatment, 1 routine clinical symptom disappearance, 5 examples take a turn for the better and take two courses of treatment again, then 2 routine clinical symptom disappearance.
2 routine muscle arthralgias, local enlargement, stiff deformity, wasting, joint stuffiness, aversion to cold and preference for warmth, brothers are wet, waist knee joint flaccidity is soft, are diagnosed as the Liver and kidney deficiency, and through taking Pill for activating collateral flow and removing spur provided by the invention after five courses of treatment, 1 example takes a turn for the better, and 1 example is invalid.
This is organized in the 18 routine rheumatoid arthritiss, produce effects 9 examples, 8 examples that take a turn for the better, invalid 1 example, effective percentage 94.4%.
In matched group 16 examples, male's 7 examples, women's 11 examples, age 21-61 year.
4 examples belong to cold dampness accumulation patterns, with Chinese medicine Aconiti Decoction plus-minus after three courses of treatment for oral administration, and 2 routine clinical symptom disappearance, 2 examples take a turn for the better.
4 examples belong to expectorant blood resistance network types, with Chinese medicine Traditional Chinese medicine decoction for treating-ache and expelling atagnate plus-minus after three courses of treatment for oral administration, and 2 routine clinical symptom disappearance, 1 example takes a turn for the better, and 1 example is invalid.
6 examples belong to phlegm-damp resistance network types, with the red small stream gout prescription plus-minus of Chinese medicine after three courses of treatment for oral administration, and 2 routine clinical symptom disappearance, 3 examples take a turn for the better, and 1 example is invalid.
2 examples belong to the Liver and kidney deficiency, and after five courses of treatment for oral administration, 1 example takes a turn for the better with the red drink plus-minus of Chinese medicine three types of Arthralgia decoction walnut, and 1 example is invalid.
This is organized in the 11 routine rheumatoid arthritiss, produce effects 6 examples, 7 examples that take a turn for the better, invalid 3 examples, effective percentage 81.3%.
32 examples are organized in II, the treatment of this group, and matched group 18 examples all belong to hyperosteogeny.Pain play, song are stretched limited, and the film making of X line sees that all hyperosteogeny sexually revises.
Treatment is organized in 32 examples, male's 11 examples, women's 21 examples, age 45-75 year.
12 routine lumbar vertebra hyperosteogeny, wherein 2 examples have hyperosteogeny concurrently, through taking Pill for activating collateral flow and removing spur provided by the invention after five courses of treatment, 4 routine clinical symptom disappearance, 7 examples take a turn for the better, and 1 example is invalid.
9 routine hyperosteogeny of cervical vertebra, through taking Pill for activating collateral flow and removing spur provided by the invention after five courses of treatment, 6 examples take a turn for the better, 2 routine clinical symptom disappearance, 1 example is invalid.
11 routine extremities joint hyperosteogenys, 3 routine clinical symptom disappearance, 6 examples take a turn for the better, 1 routine pain relief, the joint song is stretched limited, and 1 routine joint song is stretched freely, does not then have bitterly to subtract;
This is organized in the 32 routine hyperosteogenys, produce effects 9 examples, 21 examples that take a turn for the better, invalid 2 examples, effective percentage 93.8%.
In matched group 18 examples, male's 5 examples, women's 13 examples, age 41-69 year.
4 routine lumbar vertebra hyperosteogeny, with meat clothes GUCIPING PIAN, outward with acupuncture, after physical therapy five courses of treatment, 1 routine clinical symptom disappearance, 2 examples take a turn for the better, and 1 example is invalid.
8 routine hyperosteogeny of cervical vertebra, with the pink four things plus-minus of Chinese medicine for oral administration patent medicine bony spur dry tablet, outward with GUZHIZENGSHENG YITIELING, after five courses of treatment, clinical symptom disappearance 2 examples, 4 examples that take a turn for the better, invalid 2 examples.
6 routine extremities joint hyperosteogenys, with patent medicine ZHUANGGU GUANJIE WAN for oral administration, GUCIPING PIAN, GUXIAN PIAN be after five courses of treatment, 2 routine clinical symptom disappearance, 3 examples take a turn for the better, and 4 examples are invalid.
This organizes 18 routine hyperosteogenys, produce effects 5 examples, 9 examples that take a turn for the better, invalid 4 examples, effective percentage 77.8%.
40 examples are organized in III, the treatment of this group, and matched group 21 examples all belong to sciatica, symptom characteristic: pain of buttock aggravation, and walking, sitting, sneeze, bending, bend, cause pain with waist power, as boring as stinging.
Treatment is organized in 40 examples, male's 13 examples, women's 21 examples, age 28-68 year.Through taking Pill for activating collateral flow and removing spur provided by the invention after three courses of treatment, 24 routine transference cures, 14 examples take a turn for the better, and 2 examples are invalid, effective percentage 95%.
In matched group 21 examples, male's 6 examples, women's 15 examples, age 32-61 year, with after three courses of treatment of acupuncture, cupping jar, physical therapy, 3 routine transference cures, 13 examples take a turn for the better, and 5 examples are invalid, effective percentage 76.2%.
IV, utilization Pill for activating collateral flow and removing spur be to 20 routine osteopatia sprain patient observation of curative effect, male's 15 examples, women's 5 examples, age 35-47 year.After the 11 routine traumatic injury, X line film making does not have fracture, perimembranous redness, severe pain, limitation of activity, all take a favorable turn a course of treatment through taking Pill for activating collateral flow and removing spur provided by the invention, continue take 1-2 the course of treatment transference cure.9 routine osteopatia sprains be outmoded injury, limitation of activity, pain acute, do not have a fracture, through take Pill for activating collateral flow and removing spur 2-4 provided by the invention the course of treatment transference cure, effective percentage 100%.
Clinical case:
1. Ms Zhang, 46 years old, December was seen a doctor on the 16th in 1999, show as two ankle joint enlargements, pain was had a surplus in 1 year, limitation of activity, morning deadlock, stupid fiber crops, have a dizzy spell, sticking in vain, the visible sucutaneous nodule scleroma of abundant expectoration, chest distress, desire evil, poor appetite, deep pulse number, red tongue thick fur, the rheumatoid factor latex agglutination test positive general, be diagnosed as rheumatoid arthritis.Take Pill for activating collateral flow and removing spur provided by the present invention after three courses of treatment, transference cure or alleviate is taken Pill for activating collateral flow and removing spur provided by the present invention after two courses of treatment again, and clinical symptom disappearance does not have recurrence.
2. Mr. Zhang, 36 years old, on April 15th, 2000 saw a doctor, sharp ache, the difficulty that rises and retires when showing as waist center severe pain, song and stretching limited, cough, sneeze and abdominal pressure and strengthen, stride is walked lamely and emit to thigh rear side, shank after outside pain, see that through X line film making 4-5 lumbar vertebra hyperosteogeny changes, be diagnosed as lumbar vertebra hyperosteogeny, through taking Pill for activating collateral flow and removing spur that invention provides after five courses of treatment, clinical symptom disappearance does not have recurrence.
Pill for activating collateral flow and removing spur provided by the present invention has following advantage:
1. this product is than conventional medicine or Therapeutic Method efficient height.
2. this product adopts pure Chinese medicine preparation, and processing technology is simple, and side effect is little, takes with easy to carry, has strengthened the long chronic patients confidence of the taking medicine course of treatment, can reach the purpose of radical cure.
The specific embodiment:
Below in conjunction with specific embodiment the present invention is further detailed.
Embodiment 1
Press column weight amount proportioning and weigh raw material:
Radix Illicii Lanceolati, each 5 gram of Rhizoma Chuanxiong, Radix Paeoniae Alba 36 grams, Rhizoma Dioscoreae Nipponicae, Fructus Chaenomelis, Radix Clematidis, Radix Angelicae Sinensis, Radix Puerariae, Radix Dipsaci, Radix Cyathulae, Caulis Trachelospermi, Ramulus Mori, each 11 gram of Semen Persicae, Caulis Spatholobi, each 26 gram of Pumex, Flos Carthami, each 6 gram of Radix Glycyrrhizae, Rhizoma Dioscoreae 16 grams.
All raw materials are ground into the end altogether, make the Pill for activating collateral flow and removing spur of every heavy 10 grams.
Embodiment 2
Press column weight amount proportioning and weigh raw material:
Radix Illicii Lanceolati, each 15 gram of Rhizoma Chuanxiong, Radix Paeoniae Alba 46 grams, Rhizoma Dioscoreae Nipponicae, Fructus Chaenomelis, CHENGLINGXIAN, Radix Angelicae Sinensis, Radix Puerariae, Radix Dipsaci, Radix Cyathulae, Caulis Trachelospermi, Ramulus Mori, each 21 gram of Semen Persicae, Caulis Spatholobi, each 36 gram of Pumex, Flos Carthami, each 6 gram of Radix Glycyrrhizae, Rhizoma Dioscoreae 20 grams.
All raw materials are ground into the end altogether, make every heavy 10 the gram Pill for activating collateral flow and removing spur.
Embodiment 3
Press column weight amount proportioning and weigh raw material:
Radix Illicii Lanceolati, each 10 gram of Rhizoma Chuanxiong, Radix Paeoniae Alba 40 grams, Rhizoma Dioscoreae Nipponicae, Fructus Chaenomelis, Radix Clematidis, Radix Angelicae Sinensis, Radix Puerariae, Radix Dipsaci, Radix Cyathulae, Caulis Trachelospermi, Ramulus Mori, each 16 gram of Semen Persicae, Caulis Spatholobi, each 30 gram of Pumex, Flos Carthami, each 10 gram of Radix Glycyrrhizae, Rhizoma Dioscoreae 18 grams.
All raw materials are ground into the end altogether, make the Pill for activating collateral flow and removing spur of every heavy 10 grams.
Above-mentioned specific embodiment does not limit the scope of the invention, and all modifications and variations of making based on basis of the present invention all belong to the scope of protection of present invention.

Claims (2)

1, a kind of Pill for activating collateral flow and removing spur is characterized in that it is mixed and made into by weight ratio by following raw materials according:
Radix Illicii Lanceolati, each 5-15 gram of Rhizoma Chuanxiong; Radix Paeoniae Alba 36-46 gram; Rhizoma Dioscoreae Nipponicae, Fructus Chaenomelis, Radix Clematidis, Radix Angelicae Sinensis, Radix Puerariae, Radix Dipsaci, Radix Cyathulae, Caulis Trachelospermi, Ramulus Mori, each 11-21 gram of Semen Persicae; Caulis Spatholobi, each 26-36 gram of Pumex; Flos Carthami, each 6-16 gram of Radix Glycyrrhizae; Rhizoma Dioscoreae 16-20 gram.
2, a kind of preparation method of Pill for activating collateral flow and removing spur as claimed in claim 1 is characterized in that through following steps:
Select following materials of weight proportions for use:
Radix Illicii Lanceolati, each 5-15 gram of Rhizoma Chuanxiong; Radix Paeoniae Alba 36-46 gram; Rhizoma Dioscoreae Nipponicae, Fructus Chaenomelis, Radix Clematidis, Radix Angelicae Sinensis, Radix Puerariae, Radix Dipsaci, Radix Cyathulae, Caulis Trachelospermi, Ramulus Mori, each 11-21 gram of Semen Persicae; Caulis Spatholobi, each 26-36 gram of Pumex; Flos Carthami, each 6-16 gram of Radix Glycyrrhizae; Rhizoma Dioscoreae 16-20 gram;
Above-mentioned raw materials is ground into the end altogether, makes pill.
CN 03100007 2003-01-03 2003-01-03 Pill for activating collateral flow and removing spur Expired - Fee Related CN1200724C (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN 03100007 CN1200724C (en) 2003-01-03 2003-01-03 Pill for activating collateral flow and removing spur

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN 03100007 CN1200724C (en) 2003-01-03 2003-01-03 Pill for activating collateral flow and removing spur

Publications (2)

Publication Number Publication Date
CN1425446A CN1425446A (en) 2003-06-25
CN1200724C true CN1200724C (en) 2005-05-11

Family

ID=4789761

Family Applications (1)

Application Number Title Priority Date Filing Date
CN 03100007 Expired - Fee Related CN1200724C (en) 2003-01-03 2003-01-03 Pill for activating collateral flow and removing spur

Country Status (1)

Country Link
CN (1) CN1200724C (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101204474B (en) * 2007-12-12 2010-12-15 王芳 Tincture medicine for wrick
CN101444584B (en) * 2008-12-31 2011-05-18 江西本草天工科技有限责任公司 Muscle-and-tendon nourishing and bone-strengthening pharmaceutical preparation and preparation method thereof
CN101703584B (en) * 2009-11-27 2011-10-26 王瑞奇 Externally applied medicament for treating hyperosteogeny and hand-foot corn
CN104984180A (en) * 2015-07-07 2015-10-21 孙仲亮 Traditional Chinese medicine combination for treating gout and preparing method thereof

Also Published As

Publication number Publication date
CN1425446A (en) 2003-06-25

Similar Documents

Publication Publication Date Title
CN1169541C (en) Medicine for treating rheumatoid arthritis
CN1095610A (en) The pharmaceutical preparation Fubingkang of treatment, prevention gynecological diseases
CN1229658A (en) Compound sanbi medicinal liquor for treating gout
CN1350852A (en) Medicine for treating rheumatic or rheumatoid arthritis, osteoarthropathy and gout
CN1562160A (en) Composite medicine for treating hepatitis B complication
CN101041033A (en) Chinese medicine for treating hepatitis B
CN1342462A (en) Composite medicine for treating rheumatoid arthritis
CN1742979A (en) Chinese medicine for treating proliferation of mammary gland
CN100394955C (en) Chinese traditional medicine preparation for treating bone fracture and traumatic injury
CN101041043A (en) Liver cancer treating traditional Chinese medicine
CN1390585A (en) Chinese medicine for detoxication purpose and its preparing process
CN1257715A (en) Tincture for treating rheumatoid arthritis and its preparing process
CN1861155A (en) Method for preparing traditional Chinese medicine for treating rheumatism and rheumatoid disease, and said medicine thereby
CN1200724C (en) Pill for activating collateral flow and removing spur
CN1872310A (en) Preparation of Chinese traditional medicine for treating hyperosteogeny
CN1218721C (en) Chinese medicine proprietary for treating cerebrovascular and cardiovascular disease
CN101721651A (en) Traditional Chinese medicine capsule for treating scapulohumeral periarthritis
CN1840170A (en) Chinese proprietary medicine for treating cerebral thrombosis
CN1899561A (en) Ginseng spleen strengthening oral solid preparation and its preparing method
CN1076619C (en) Moxiburning medicine for acupoint therapy
CN1308025C (en) Medicine for treating paraplegia and its preparing method
CN1253196C (en) Medicine for treating colitis
CN1279948C (en) Medicine for treating arthritis and atrophic arthritis
CN1270791C (en) Kidney disease, urinemia therapeutic instrument and its matched medicinal compositon
CN102988833A (en) Traditional Chinese medicine composition for treating rheumatism

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
C19 Lapse of patent right due to non-payment of the annual fee
CF01 Termination of patent right due to non-payment of annual fee